Contact
searchSearch
HMP Global

General Neurology Topic Center

Recent News and Updates

broken DNA strand
News
Gene Therapy May Offer an Effective Alternative to Cochlear Implantation in Patients With Congenital Deafness
07/25/2025
Maria Mantas
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital...
07/25/2025
Neurology
Doctors examine brain scans
News
GLP-1 RAs May Offer Novel Approach for Idiopathic Intracranial Hypertension Management
07/21/2025
Jolynn Tumolo
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic...
07/21/2025
Neurology
Alzheimer Disease & Cognitive Disorders Symposium
Conference Coverage
Alzheimer's Disease and Cognitive Disorders Symposium: Agenda Highlights
07/17/2025
Marwan Sabbagh, MD
Learn more about the Alzheimer's Disease and Cognitive Disorder Symposium with this video from Co-Chair Marwan Sabbagh, MD, FAAN, FANA.
Learn more about the Alzheimer's Disease and Cognitive Disorder Symposium with this video from Co-Chair Marwan Sabbagh, MD, FAAN, FANA.
Learn more about the Alzheimer's...
07/17/2025
Neurology
ADCD symposium
Conference Coverage
Introducing the Alzheimer's Disease and Cognitive Disorders Symposium
07/07/2025
Marc E. Agronin, MD; W. Clay Jackson, MD, DipTh
Meeting co-chairs Marc Agronin and W. Clay Jackson introduce this new symposium and share why healthcare providers should attend.
Meeting co-chairs Marc Agronin and W. Clay Jackson introduce this new symposium and share why healthcare providers should attend.
Meeting co-chairs Marc Agronin...
07/07/2025
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Association Found Between Psychiatric Medication Use and Risk of ALS
06/18/2025
Brionna Mendoza
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has...
06/18/2025
Neurology
diagnosing brain injury
News
Intensive Blood Pressure Reduction After ICH Not Linked to Ischemic Lesions
04/28/2025
Meagan Thistle
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood...
04/28/2025
Neurology
A new mom sits on the couch holding her infant, and her forehead
News
Gestational Hypertension, Preeclampsia, and Eclampsia Associated With Greater Incidence of Future Neurological Disorders
02/13/2025
Brionna Mendoza
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of...
02/13/2025
Neurology
A person holds a cannabis joint in their hands
News
Cannabis Use Linked With Diminished Brain Activation in Young Adults
02/11/2025
Jolynn Tumolo
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy...
02/11/2025
Neurology
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
News
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
02/05/2025
Jolynn Tumolo
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive...
02/05/2025
Neurology
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
News
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
02/03/2025
Jolynn Tumolo
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess...
02/03/2025
Neurology
Before what gestational age can brain death not be determined?
Quiz
Before what gestational age can brain death not be determined?
01/13/2025
Test your guideline knowledge!
Test your guideline knowledge!
Test your guideline knowledge!
01/13/2025
Neurology

Quizzes

Before what gestational age can brain death not be determined?
Quiz
Before what gestational age can brain death not be determined?
01/13/2025
Test your guideline knowledge!
Test your guideline knowledge!
Test your guideline knowledge!
01/13/2025
Neurology
quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
How does serious mental illness affect risk of death after COVID-19 infection?
11/29/2023
Test your clinical knowledge with this quiz!
Test your clinical knowledge with this quiz!
Test your clinical knowledge...
11/29/2023
Neurology
Pencils spell out quiz.
Quiz
What kind of brain inflammation does COVID-19 infection cause?
04/12/2023
Test your neurology knowledge with this quiz!
Test your neurology knowledge with this quiz!
Test your neurology knowledge...
04/12/2023
Neurology
Some heart-healthy foods, including fruits and vegetables.
Quiz
How much can a heart-healthy lifestyle reduce stroke risk in those with high genetic risk?
08/12/2022
Take the quiz to test your neurology knowledge!
Take the quiz to test your neurology knowledge!
Take the quiz to test your...
08/12/2022
Neurology
People raising hands to answer question.
Quiz
Which conditions did access to medical marijuana improve?
07/15/2022
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
07/15/2022
Neurology
Pop quiz written on a blackboard with white chalk
Expert Insights Quiz
Mimics in Excessive Daytime Sleepiness
09/10/2025
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
09/10/2025
Neurology
quiz
Quiz
Early DOAC Initiation in AF-Related Ischemic Stroke
08/27/2025
Maria Mantas
Do you remember the details of this meta-analysis?
Do you remember the details of this meta-analysis?
Do you remember the details of...
08/27/2025
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
Vyalev Contraindications
07/29/2025
Brionna Mendoza
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/29/2025
Neurology
four people ponder a question with question marks over their head
Quiz
Dopaminergic Therapy in Early Parkinson Disease
07/10/2025
Test your guideline knowledge with this quick quiz!
Test your guideline knowledge with this quick quiz!
Test your guideline knowledge...
07/10/2025
Neurology
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
Quiz
Head Positioning Before Thrombectomy
06/25/2025
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
06/25/2025
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
Epidural Steroids for Spinal Stenosis
06/12/2025
Brionna Mendoza
Test your clinical guideline knowledge with this quick quiz!
Test your clinical guideline knowledge with this quick quiz!
Test your clinical guideline...
06/12/2025
Neurology
illustration of a laptop screen displaying a test
Quiz
Effective Treatment Approaches for Menstrual Migraine
05/12/2025
Maria Mantas
Brush up on your knowledge of treatment approaches for menstrual migraines!
Brush up on your knowledge of treatment approaches for menstrual migraines!
Brush up on your knowledge of...
05/12/2025
Neurology
illustration of a test
Quiz
Which factors increase the risk of late-onset epilepsy (LOE) in people with cognitive decline?
04/23/2025
Maria Mantas
Do you remember the risk factors for late-onset epilepsy (LOE) in patients with cognitive decline?
Do you remember the risk factors for late-onset epilepsy (LOE) in patients with cognitive decline?
Do you remember the risk factors...
04/23/2025
Neurology
Take the Quiz!
Quiz
Parkinson Disease Diagnosis: Test Your Knowledge of Clinical Criteria
03/07/2025
Meagan Thistle
Think you know the key clinical features required to diagnose Parkinson disease? Put your knowledge of MDS criteria to the test!
Think you know the key clinical features required to diagnose Parkinson disease? Put your knowledge of MDS criteria to the test!
Think you know the key clinical...
03/07/2025
Neurology
A wrench with the word 'pain' on it holds the head of a wooden figurine in a vice grip
Quiz
Acute or Preventative Migraine Treatment?
01/28/2025
Test your knowledge of practice guidelines with this quiz!
Test your knowledge of practice guidelines with this quiz!
Test your knowledge of practice...
01/28/2025
Neurology

News

broken DNA strand
News
Gene Therapy May Offer an Effective Alternative to Cochlear Implantation in Patients With Congenital Deafness
07/25/2025
Maria Mantas
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital...
07/25/2025
Neurology
Doctors examine brain scans
News
GLP-1 RAs May Offer Novel Approach for Idiopathic Intracranial Hypertension Management
07/21/2025
Jolynn Tumolo
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic...
07/21/2025
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Association Found Between Psychiatric Medication Use and Risk of ALS
06/18/2025
Brionna Mendoza
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has...
06/18/2025
Neurology
diagnosing brain injury
News
Intensive Blood Pressure Reduction After ICH Not Linked to Ischemic Lesions
04/28/2025
Meagan Thistle
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood...
04/28/2025
Neurology
A new mom sits on the couch holding her infant, and her forehead
News
Gestational Hypertension, Preeclampsia, and Eclampsia Associated With Greater Incidence of Future Neurological Disorders
02/13/2025
Brionna Mendoza
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of...
02/13/2025
Neurology
A person holds a cannabis joint in their hands
News
Cannabis Use Linked With Diminished Brain Activation in Young Adults
02/11/2025
Jolynn Tumolo
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy...
02/11/2025
Neurology
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
News
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
02/05/2025
Jolynn Tumolo
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive...
02/05/2025
Neurology
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
News
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
02/03/2025
Jolynn Tumolo
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess...
02/03/2025
Neurology
Brain health
News
Mood Changes May Be a Prodromal Symptom in Sporadic Creutzfeldt-Jakob Disease
01/09/2025
Brionna Mendoza
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom...
01/09/2025
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Jolynn Tumolo
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
two researchers look at computer screen in lab medical research
News
Apitegromab Improves Motor Function in Children With SMA
09/24/2025
Jolynn Tumolo
Treatment with the fully human monoclonal antibody apitegromab was associated with statistically significant improvements in motor function scores compared with placebo in patients with type 2 or type 3 spinal muscular atrophy (SMA).
Treatment with the fully human monoclonal antibody apitegromab was associated with statistically significant improvements in motor function scores compared with placebo in patients with type 2 or type 3 spinal muscular atrophy (SMA).
Treatment with the fully human...
09/24/2025
Neurology
a woman sits up in bed holding her head insomnia
News
Insomnia Linked With Cognitive Decline in Older Adults
09/23/2025
Jolynn Tumolo
Older adults with chronic insomnia were 40% more likely to develop mild cognitive impairment or dementia over a median 5.6 years compared with older adults without insomnia, according to a study published in Neurology.
Older adults with chronic insomnia were 40% more likely to develop mild cognitive impairment or dementia over a median 5.6 years compared with older adults without insomnia, according to a study published in Neurology.
Older adults with chronic...
09/23/2025
Neurology
an illustration of a head in profile with brain against a pink background
News
Noninvasive Physiomarker Identifies MCI and AD With High Accuracy
09/16/2025
Jolynn Tumolo
A novel physiological marker that quantifies the regulation dynamics of cerebral perfusion and oxygenation surpassed the performance of cognitive assessment tests and amyloid positron emission tomography (PET) in differentiating patients with...
A novel physiological marker that quantifies the regulation dynamics of cerebral perfusion and oxygenation surpassed the performance of cognitive assessment tests and amyloid positron emission tomography (PET) in differentiating patients with...
A novel physiological marker...
09/16/2025
Neurology
A man lies in bed on his back with a sleep mask on and mouth hanging open while asleep
News
Sleep Regularity Linked With Better Cognition, But Balance Patterns Best for BDNF
09/15/2025
Jolynn Tumolo
While regularity in day-to-day sleep patterns appears beneficial for cognitive function, sleep patterns that are rigid or highly regular may not be optimal in terms of serum brain-derived neurotrophic factor (BDNF).
While regularity in day-to-day sleep patterns appears beneficial for cognitive function, sleep patterns that are rigid or highly regular may not be optimal in terms of serum brain-derived neurotrophic factor (BDNF).
While regularity in day-to-day...
09/15/2025
Neurology
FDA approval stamp
News
FDA Approves Subcutaneous Injection for Maintenance Treatment of Early AD
09/11/2025
Maria Mantas
The US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once-weekly subcutaneous lecanemab-irmb injections (LEQEMBI IQLIK) for the maintenance treatment of early Alzheimer disease (AD).
The US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once-weekly subcutaneous lecanemab-irmb injections (LEQEMBI IQLIK) for the maintenance treatment of early Alzheimer disease (AD).
The US Food and Drug...
09/11/2025
Neurology
brain scan
News
Moderate to Severe TBI Linked With Development of Malignant Brain Tumors
09/08/2025
Jolynn Tumolo
A history of moderate to severe traumatic brain injury (TBI) in US adult civilians was associated with an increased risk of developing a malignant brain tumor over follow-up.
A history of moderate to severe traumatic brain injury (TBI) in US adult civilians was associated with an increased risk of developing a malignant brain tumor over follow-up.
A history of moderate to severe...
09/08/2025
Neurology
A woman lies in bed with her mouth open snoring sleep apnea
News
New AASM Patient-Reported Outcome Tool Valid for Monitoring Sleep Apnea
09/08/2025
Jolynn Tumolo
A patient-reported outcome tool developed by the American Academy of Sleep Medicine (AASM) is clinically valid, reliable, and feasible for monitoring treatment response and longitudinal symptom progression in adults with obstructive sleep...
A patient-reported outcome tool developed by the American Academy of Sleep Medicine (AASM) is clinically valid, reliable, and feasible for monitoring treatment response and longitudinal symptom progression in adults with obstructive sleep...
A patient-reported outcome tool...
09/08/2025
Neurology
Mediterranean diet
News
Mediterranean Diet May Mitigate Genetic Risk for Alzheimer Disease
09/05/2025
Brionna Mendoza
For those carrying the APOE4 gene, following a Mediterranean diet may lower the risk of developing Alzheimer disease and dementia, suggest study results published in Nature Medicine.
For those carrying the APOE4 gene, following a Mediterranean diet may lower the risk of developing Alzheimer disease and dementia, suggest study results published in Nature Medicine.
For those carrying the APOE4...
09/05/2025
Neurology
An illustration of a brain with a puzzle piece missing, surrounded by doctors with elderly patients
News
In Early Trial, Ambroxol Shows Promise for Parkinson Disease Dementia
09/02/2025
Jolynn Tumolo
A drug used in Europe for treating respiratory conditions was safe, well-tolerated, and demonstrated target engagement in patients with Parkinson disease dementia (PDD).
A drug used in Europe for treating respiratory conditions was safe, well-tolerated, and demonstrated target engagement in patients with Parkinson disease dementia (PDD).
A drug used in Europe for...
09/02/2025
Neurology
A head in profile with cogs coming out of it against an orange background
News
Less Than a Third of Patients With Focal Epilepsy Become Seizure-Free on First ASM
08/26/2025
Jolynn Tumolo
Most patients with newly diagnosed focal epilepsy require more than 1 antiseizure medication (ASM) and more than 1 year to achieve seizure freedom.
Most patients with newly diagnosed focal epilepsy require more than 1 antiseizure medication (ASM) and more than 1 year to achieve seizure freedom.
Most patients with newly...
08/26/2025
Neurology

Migraine CME Series

News

broken DNA strand
News
Gene Therapy May Offer an Effective Alternative to Cochlear Implantation in Patients With Congenital Deafness
07/25/2025
Maria Mantas
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital...
07/25/2025
Neurology
Doctors examine brain scans
News
GLP-1 RAs May Offer Novel Approach for Idiopathic Intracranial Hypertension Management
07/21/2025
Jolynn Tumolo
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic...
07/21/2025
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Association Found Between Psychiatric Medication Use and Risk of ALS
06/18/2025
Brionna Mendoza
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has...
06/18/2025
Neurology
diagnosing brain injury
News
Intensive Blood Pressure Reduction After ICH Not Linked to Ischemic Lesions
04/28/2025
Meagan Thistle
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood...
04/28/2025
Neurology
A new mom sits on the couch holding her infant, and her forehead
News
Gestational Hypertension, Preeclampsia, and Eclampsia Associated With Greater Incidence of Future Neurological Disorders
02/13/2025
Brionna Mendoza
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of...
02/13/2025
Neurology
A person holds a cannabis joint in their hands
News
Cannabis Use Linked With Diminished Brain Activation in Young Adults
02/11/2025
Jolynn Tumolo
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy...
02/11/2025
Neurology
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
News
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
02/05/2025
Jolynn Tumolo
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive...
02/05/2025
Neurology
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
News
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
02/03/2025
Jolynn Tumolo
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess...
02/03/2025
Neurology
Brain health
News
Mood Changes May Be a Prodromal Symptom in Sporadic Creutzfeldt-Jakob Disease
01/09/2025
Brionna Mendoza
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom...
01/09/2025
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Jolynn Tumolo
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
two researchers look at computer screen in lab medical research
News
Apitegromab Improves Motor Function in Children With SMA
09/24/2025
Jolynn Tumolo
Treatment with the fully human monoclonal antibody apitegromab was associated with statistically significant improvements in motor function scores compared with placebo in patients with type 2 or type 3 spinal muscular atrophy (SMA).
Treatment with the fully human monoclonal antibody apitegromab was associated with statistically significant improvements in motor function scores compared with placebo in patients with type 2 or type 3 spinal muscular atrophy (SMA).
Treatment with the fully human...
09/24/2025
Neurology
a woman sits up in bed holding her head insomnia
News
Insomnia Linked With Cognitive Decline in Older Adults
09/23/2025
Jolynn Tumolo
Older adults with chronic insomnia were 40% more likely to develop mild cognitive impairment or dementia over a median 5.6 years compared with older adults without insomnia, according to a study published in Neurology.
Older adults with chronic insomnia were 40% more likely to develop mild cognitive impairment or dementia over a median 5.6 years compared with older adults without insomnia, according to a study published in Neurology.
Older adults with chronic...
09/23/2025
Neurology
an illustration of a head in profile with brain against a pink background
News
Noninvasive Physiomarker Identifies MCI and AD With High Accuracy
09/16/2025
Jolynn Tumolo
A novel physiological marker that quantifies the regulation dynamics of cerebral perfusion and oxygenation surpassed the performance of cognitive assessment tests and amyloid positron emission tomography (PET) in differentiating patients with...
A novel physiological marker that quantifies the regulation dynamics of cerebral perfusion and oxygenation surpassed the performance of cognitive assessment tests and amyloid positron emission tomography (PET) in differentiating patients with...
A novel physiological marker...
09/16/2025
Neurology
A man lies in bed on his back with a sleep mask on and mouth hanging open while asleep
News
Sleep Regularity Linked With Better Cognition, But Balance Patterns Best for BDNF
09/15/2025
Jolynn Tumolo
While regularity in day-to-day sleep patterns appears beneficial for cognitive function, sleep patterns that are rigid or highly regular may not be optimal in terms of serum brain-derived neurotrophic factor (BDNF).
While regularity in day-to-day sleep patterns appears beneficial for cognitive function, sleep patterns that are rigid or highly regular may not be optimal in terms of serum brain-derived neurotrophic factor (BDNF).
While regularity in day-to-day...
09/15/2025
Neurology
FDA approval stamp
News
FDA Approves Subcutaneous Injection for Maintenance Treatment of Early AD
09/11/2025
Maria Mantas
The US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once-weekly subcutaneous lecanemab-irmb injections (LEQEMBI IQLIK) for the maintenance treatment of early Alzheimer disease (AD).
The US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once-weekly subcutaneous lecanemab-irmb injections (LEQEMBI IQLIK) for the maintenance treatment of early Alzheimer disease (AD).
The US Food and Drug...
09/11/2025
Neurology
brain scan
News
Moderate to Severe TBI Linked With Development of Malignant Brain Tumors
09/08/2025
Jolynn Tumolo
A history of moderate to severe traumatic brain injury (TBI) in US adult civilians was associated with an increased risk of developing a malignant brain tumor over follow-up.
A history of moderate to severe traumatic brain injury (TBI) in US adult civilians was associated with an increased risk of developing a malignant brain tumor over follow-up.
A history of moderate to severe...
09/08/2025
Neurology
A woman lies in bed with her mouth open snoring sleep apnea
News
New AASM Patient-Reported Outcome Tool Valid for Monitoring Sleep Apnea
09/08/2025
Jolynn Tumolo
A patient-reported outcome tool developed by the American Academy of Sleep Medicine (AASM) is clinically valid, reliable, and feasible for monitoring treatment response and longitudinal symptom progression in adults with obstructive sleep...
A patient-reported outcome tool developed by the American Academy of Sleep Medicine (AASM) is clinically valid, reliable, and feasible for monitoring treatment response and longitudinal symptom progression in adults with obstructive sleep...
A patient-reported outcome tool...
09/08/2025
Neurology
Mediterranean diet
News
Mediterranean Diet May Mitigate Genetic Risk for Alzheimer Disease
09/05/2025
Brionna Mendoza
For those carrying the APOE4 gene, following a Mediterranean diet may lower the risk of developing Alzheimer disease and dementia, suggest study results published in Nature Medicine.
For those carrying the APOE4 gene, following a Mediterranean diet may lower the risk of developing Alzheimer disease and dementia, suggest study results published in Nature Medicine.
For those carrying the APOE4...
09/05/2025
Neurology
An illustration of a brain with a puzzle piece missing, surrounded by doctors with elderly patients
News
In Early Trial, Ambroxol Shows Promise for Parkinson Disease Dementia
09/02/2025
Jolynn Tumolo
A drug used in Europe for treating respiratory conditions was safe, well-tolerated, and demonstrated target engagement in patients with Parkinson disease dementia (PDD).
A drug used in Europe for treating respiratory conditions was safe, well-tolerated, and demonstrated target engagement in patients with Parkinson disease dementia (PDD).
A drug used in Europe for...
09/02/2025
Neurology
A head in profile with cogs coming out of it against an orange background
News
Less Than a Third of Patients With Focal Epilepsy Become Seizure-Free on First ASM
08/26/2025
Jolynn Tumolo
Most patients with newly diagnosed focal epilepsy require more than 1 antiseizure medication (ASM) and more than 1 year to achieve seizure freedom.
Most patients with newly diagnosed focal epilepsy require more than 1 antiseizure medication (ASM) and more than 1 year to achieve seizure freedom.
Most patients with newly...
08/26/2025
Neurology

Alzheimer's Disease CME Series

Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use